Get started
Author

Dalia Makhlouf

Observed names: D. Makhlouf, Dalia O. Makhlouf, Makhlouf, Dalia
ORCID: 0009-0003-7880-544X
Observed ORCID: 0009-0003-7880-544X
OpenAlex ID: A5040501445
MicroRNAs 182 and 375 Sera Expression as Prognostic Biochemical Markers in Breast Cancer
2018 · Ola S. Ali, Marwa I. Shabayek, et al. · Clinical Breast Cancer · 17
Efficacy and Toxicity of Vincristine and CYP3A5 Genetic Polymorphism in Rhabdomyosarcoma Pediatric Egyptian Patients
2024 · Norhan Shalaby, Hala Zaki, et al. · Asian Pacific Journal of Cancer Prevention · 9
Correlation of Genetic Polymorphism of CYP3A5 to Cyclophosphamide Efficacy and Toxicity in Rhabdomyosarcoma Pediatric Egyptian Cancer Patients
2024 · Cherine ElShereef, Hala Zaki, et al. · Asian Pacific Journal of Cancer Prevention · 6
Analysis of the current situation of pharmacogenomics in terms of educational and healthcare needs in Egypt and Lebanon
2024 · Sahar M El-Gowilly, Heba A Metwaly, et al. · Pharmacogenomics · 3
PDF
Evaluating the impact of infectious disease pharmacy services on voriconazole dose individualization in pediatric oncology
2025 · Mai Samy Azab, Dalia Makhlouf, et al. · Personalized Medicine · 1
Tailoring pediatric vancomycin doses: achieving therapeutic levels and minimizing toxicity in oncology patients
2025 · Nadeen Hossam, Dalia Makhlouf, et al. · Personalized Medicine
Surgical Management of Congenital Hyperinsulinism: Our Experience
2021 · D. Makhlouf, N. Kechiche, et al. · Metabolism
Works count: 8
Citation count: 36
H-index: 3
I10-index: 1
Year
Topic
Type